Latest News & Updates

Nationwide Recall of Docetaxel Issued Over Particulate Concerns
June 7, 2024

Continue Reading »

New Cervical Cancer Guidelines Released
March 26, 2024

Continue Reading »

Judge Grants Biden Administration Motion to Dismiss Legal Challenge from PhRMA
February 26, 2024

Continue Reading »

Session Midpoint Report: What Physicians Should Know
February 21, 2024

Continue Reading »

FDA grants accelerated approval to repotrectinib for adult and pediatric patients with NTRK gene fusion-positive solid tumors
June 13, 2024

Continue Reading »

FDA approves selpercatinib for RET fusion-positive thyroid cancer
June 13, 2024

Continue Reading »

FDA approves imetelstat for low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia
June 7, 2024

Continue Reading »

Get More from FLASCO With Your Partnership

The Corporate Partnership Program allows FLASCO to expand our offerings to our partneres. Every FLASCO meeting also provides the industry representative with opportunities to educate our partners. When you send representatives to a FLASCO meeting, you are allowing them to share their knowledge, as well as receive the same knowledge as our members by participating within the educational sessions. This helps ensure that the hematology and oncology community at large are learning, sharing best practices, and finding solutions to problems together.

Corporate Partners

Diamond Elite

Diamond

Platinum

Gold

Upcoming Events

Click to view full events calendar.

We're Here to Help Contact Us

Contact Us

Add your name, email & message below: